Microencapsulated genetically engineered E. coli DH5 cells for plasma urea and ammonia removal based on : 1. Column bioreactor and 2. Oral administration in uremic rats

Artificial Cells, Blood Substitutes, and Immobilization Biotechnology

Volumn 24, Issue 3, 1996, Pages 201-218

  Prakash, S ^a   Chang, T M S ^a  

^a MCGILL UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

AMMONIA; BACTERIA; BIOREACTORS; DRUG THERAPY; GENETIC ENGINEERING; UREA;

ARTIFICIAL CELLS; COLUMN BIOREACTOR; ESCHERICHIA COLI; MICROENCAPSULATION; ORAL ADMINISTRATION; PLASMA UREA; UREMIC RATS;

CELLS;

AMMONIA; UREA;

AMMONIA BLOOD LEVEL; ANIMAL EXPERIMENT; ARTICLE; BIOREACTOR; CONTROLLED STUDY; ESCHERICHIA COLI; GENETIC ENGINEERING; MICROENCAPSULATION; NONHUMAN; RAT; UREA BLOOD LEVEL; UREMIA;

ADMINISTRATION, ORAL; AMMONIA; ANIMALS; BIOREACTORS; DRUG COMPOUNDING; EQUIPMENT DESIGN; ESCHERICHIA COLI; EVALUATION STUDIES; GENETIC ENGINEERING; RATS; UREA; UREMIA;

ANIMALIA; ESCHERICHIA COLI;

EID: 0030013792     PISSN: 10731199     EISSN: None     Source Type: Journal    
DOI: 10.3109/10731199609117436     Document Type: Article

References (49)

1. Griffin , A.M. and Griffin, H.G. (1995), In: Molecular Biology : current innovations and future trends part 2, Oct., Horizon Scientific Press, England.
2. Mange, Arthur P. (Nov. 1984), In: Applied Genetic Engineering; future trends and problems, Noyes Publs., Bioscience.34, 642.
3. Carmen, A.M. (1992), Am. J. of Human Genetics. 50:245-260.
4. Chang, T.M.S. (1964), Semipermeable Microcapsules. Science. 146 (3643): 524-525.
5. Chang, T.M.S., and Poznansky, M.J. (1968), Semipermeable Microcapsules containing catalase for enzyme replacement in catalasaemic mice. Nature (London), 218, 243-245.
6. Chang, T.M.S. (1988), Methods in the medical application of immobilized proteins enzymes and cells. Methods in Enzymology. 137: 444-457.
7. Chang, T.M.S. (1993). Living cells and microorganisms immobilized by microencapsulation inside artificial cells. pp. 183-194. In: Goosen, M.F. (Ed.), Fundamentals of animal cell encapsulation and Immobilization. CRC press, N.Y.
8. Dayton, Leigh (1989), Cells by design, New Scientist, 3 June, 42-43.
9. Chang, T.M.S. (1995), Artificial cells with emphasis on bioencapsulation in biotechnology in Annual Review of Biotechnology (M.R. El-Gewely (Ed.), Elsevier Science B.V.
10. Chang, T.M.S. (1972a), Artificial Cells. Thomas, Springfield, Illinois.
11. Chang, T.M.S. (1978), Artificial Kidney, Artificial Liver, and Artificial Cells. Plenum Press, New York.
12. Charles, S., David, M., Stacia, M. (1990), pp. 526-527. In: Deborah, A. (Ed.), Human physiology : foundations and frontiers.
13. Drukker, W., Parsons, P.M., and Mahar, J.F. (1983), Replacement of renal functions by dialysis. Martin, Nijhoff Publ. (Boston).
14. Friedman ,E.A.(1978), In : Eli, A. Friedman (Ed.), Strategy in renal failure, pp. 521-528.Wily & Sons, N.Y.
15. Chang, T.M.S. (1969a), Removal of endogenous and exogenous toxins by a microencapsulated adsorbent. Can. J. Physiol. Pharmacol., 47(12), 1043-1045.
16. Kolff, W.J. (1990), Artificial kidney and artificial heart : future considerations. Int. J. Artificial Organs. 13(7): 404-406.
17. Sparks, R.E. (1979), Review of gastrointestinal perfusion in treatment of uraemia. Clin. Nephro. 11:81.
18. Chang, T.M.S., Malouf,C., and Resurreccion, E. (1979), Artificial cells containing multienzyme systems for the sequential conversion of urea into ammonia, glutamate, then alanine. Artif. Org., 3, S284-S287.
19. Gu, K.F. and Chang, T.M.S. (1991), Conversion of urea or ammonia in to essential amino acids, L-leucine, L-valine and L-isoleucine using artificial cells containing an immobilized multienzyme system and dextran-NAD. Yeast alcohol dehydrogenase for enzyme recycling. J. Biotech. Applied Biochem. 12: 227-236.
20. Gu, K.F. and Chang, T.M.S. (1988), Conversion of alpha-ketogluterate into L- glutamic acid with urea as ammonia source using multienzyme system and NAD immobilized by microencapsulation with artificial cell in bioreactor. Biotechnol. Bioengg. 32: 363-368.
21. Esposito, R. Carmelo, G. (1980), Polyhalides. pp. 133-153. In : Giordano Caramelo (ed.), Sorbents and their clinical applications. Academic press, London.
22. Gardner, D. L., Kjellstrand, C. M., Fink, D.J., and Emmerling, D.C. (1984), Oral administration of microencapsulated urease and zirconium phosphate. Artif. Org., 8, 110.
23. Kjellstrand, G., Borger, H. Pru, G.G. and Fink, D. (1981), Trans. Am. Soc. of Artificial Internal Organs. 27: 24-30.
24. Chang, T.M.S., and Loa, S.K. (1970), Urea removal by urease and ammonia absorbents in the intestine. The Physiologist, 13(3), 70.
25. Chang, T.M.S. (1985), Biotechnology of artificial cells including application to artificial organs. In comprehensive biotechnology : the principle applications & regulation of biotechnology in industry agriculture and medicine. pp. 53-73. In : Murray Moo Young (Ed.), Pergamon press, N.Y.
26. Man, N.K., Drueke,T., Becker,A., Zingraff J., Jungers,P., and Brentano, J.L.F. (1976), Clinical use of oxystarch. Kid. Int., 10, S269-S272.
27. Walker, J.M., Jacobson, R.L., Stephen, W.J., and Rose, D. (1977), The role of adsorbents in the wearable artificial kidney, pp. 137-149. In : Gilchrit, T. (Ed.), Artificial Organs. Macmillan Press, London.
28. Hughes, R., and Williams, R. (1981), Clinical experience with charcoal and resin hemoperfusion, Seminars in liver disease 6(2): 169-172.
29. Juggi, J.S. (1973), Extracorporeal cation-exchange circuits in the treatment of hyperammonemia of liver failure. Med. J. Aust., 1, 926-930.
30. Cattaneo, M. Chang. T.M.S. (1991), The potential of microencapsulated urease- zeolite oral sorbent for the removal of urea in uraemia. TASAIO-official J. of American Society of Artificial Internal Organs. 37: 80-87.
31. Setala, K., Heinonen, H. and Schreck-Purla (1973), Ingestion of lyophilized soil bacteria for alleviation of uremic symptoms. J. Int. Res. Comm. System. 73.
32. Giordano, C., Esposito, R., and Pluvio, M. (1976), Further studies with oxystarch. Kid. Int., 10, S266-S268.
33. Setala, K., Heinonen, H. and Schreck-Purla (1972), Uremic waste recovery. Proceeding Conf. E.D.T.A. 9: 514-520.
34. Prakash, S. and Chang, T.M.S. (1993), Microencapsulated genetically engineered E. Coli cells containing genes form K. aerogens for urea and ammonia removal. Biomat. Artifi.Cells & Immob. Biotech., 19(4):687-697.
35. Prakash, S. and T.M.S. Chang (1995), Preparation and in-vitro analysis of genetically engineered E. coli cells, microencapsulated in artificial cells for urea and ammonia removal : Biotechnology and Bioengineering, Vol. 47, 629-626, John Willy and Sons Co., USA.
36. Prakash, S. and T.M.S. Chang (1996), A new approach of using artificial cells containing genetically engineered E. coli DH5 cells for urea and ammonia removals. Submitted ASAIO journal, 1996.
37. Marines et al. (1994), F. and White, D.W.R.: Immobilization of E. coli expressing the lux gene of Xenorhabdus luminescence; Applied
38. Chang,T.M.S. and Prakash, S. (1995), Artificial cells for bioencapsulation of cells and genetically engineered E. coli : For cell therapy, gene therapy and removal of urea and ammonia, In : Methods in Molecular Biology, Volume on "Expression and Detection of Recombinant Gene". Humana Press, USA Chapter 75 (in press).
39. Scoot, B., Mulrooney, H. Stauart, P. and Haussinger, R.P. (1989), Regulation of gene expression and cellular localization of cloned K. aerogens urease. J. of Gen. Microbiol. 135: 1769-1776.
40. Mobley, H.L, and Haussinger, R.P. (9989), Microbial ureases : significance, regulation, and molecular characterisation. Microbiolo. Rev. 53(1): 85-108.
41. Castelman, B. and Betty, U. McNeely. 1974. Case records of the Massachusetts general hospital. New Engl. J. of Med., Vol.290 No.1:39-49.
42. Chang, T.M.S. (1972), Hemoperfusion over microencapsulated adsorbent in a patient with hepatic coma. Lancet II, 1371-1372.
43. Chang, T.M.S. (1984), Liver support systems. In : "Life support system in intensive care", Bartelett et al, ed., Year Book Med. Publ., Chicago. 61-485.
44. Chang, T.M.S. (1987), Recycling of NAD(P) by multienzyme systems immobilized by microencapsulation in artificial cells. In Methods in Enzymology In : Mosbach, K. (Ed.) ,Vol. 136, pp.67-82, Academic Press, New York.
45. Kwok, W.Y., Kiparissides, C., Yuet, P., Harris, T.J. and Goosen, M.F. (1991), Mathematical modelling of protein diffusion in microcapsules : a comparison with experimental results. The Canadian Journal of Chemical Engineering. 69(Feb.): 360-370.
46. Wong, H. and Chang, T.M.S. (1991), A novel two step procedure for Immobilization of living cells in microcapsules for improving xenograft survival. Biomat., Artifi. Cells and Immob. Biotech. 19(4): 687-697.
47. Taillandier, P., Cazottes, M. L., and Strehaiano, P. (1994), Deacidification of grape musts by Schizosaccharomyces entrapped in alginate beads : a continuous-fluidized-bed process. The Chem. Eng. Journal, 55:B29-B33
48. Sarvedra M. J., Baumann N., Oung, L, Perman, J. and Yolken R.H. (1995), Feeding of Bifidobacterium bifidum and Streptococcus thermophilus to infants in hospital for prevention of diarrhea and shedding of rotavirus. Lancet. 344, 1046-1049.
49. Freter, R., Brickner, H., Fekete, J., Vicraman, M., M., and Carey, E. (1983), Survival and implantation of E. coli in the intestinal tract. Infection and Immunity. 39, 686-703.